Cellular‐specific role of toll‐like receptor 4 in hepatic ischemia‐reperfusion injury in mice
暂无分享,去创建一个
D. Stolz | T. Billiar | A. Tsung | D. Geller | D. Hackam | C. Sodhi | R. Shapiro | Hai Huang | S. Korff | J. Klune | Raymond E. Eid | B. Rosborough | G. Nace | Shen Li
[1] T. Billiar,et al. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. , 2012, Gastroenterology.
[2] M. Kay,et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. , 2011, The Journal of clinical investigation.
[3] R. Schnellmann,et al. Toll‐like receptor 4 knockout mice are protected from endothelial overactivation in the absence of Kupffer cells after total hepatic ischemia/reperfusion , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] C. Esmon,et al. Endogenous Histones Function as Alarmins in Sterile Inflammatory Liver Injury Through Toll-like Receptor 9 in Mice , 2011, Hepatology.
[5] T. Billiar,et al. Interferon Regulatory Factor 1 Mediates Acetylation and Release of High Mobility Group Box 1 from Hepatocytes During Murine Liver Ischemia-Reperfusion Injury , 2011, Shock.
[6] Jason P. Zlotnicki,et al. High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity* , 2010, The Journal of Biological Chemistry.
[7] M. Giovannini,et al. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. , 2010, Genes & development.
[8] R. Schnellmann,et al. Murine Kupffer Cells Are Protective in Total Hepatic Ischemia/Reperfusion Injury with Bowel Congestion through IL-10 , 2010, The Journal of Immunology.
[9] G. Plitas,et al. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. , 2010, The Journal of clinical investigation.
[10] Zhang Jinxiang,et al. Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. , 2009, Biochemical and biophysical research communications.
[11] Wenjing Zhang,et al. c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer. , 2008, Carcinogenesis.
[12] G. Cheng,et al. Evidence for the Pivotal Role of Endogenous Toll-Like Receptor 4 Ligands in Liver Ischemia and Reperfusion Injury , 2008, Transplantation.
[13] M. Rosengart,et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling , 2007, The Journal of experimental medicine.
[14] S. Chadban,et al. TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.
[15] B. Reizis,et al. Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.
[16] M. Lotze,et al. Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.
[17] K. Tracey,et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.
[18] Ryan M. O’Connell,et al. Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway1 , 2004, The Journal of Immunology.
[19] T. Billiar,et al. TISSUE HYPOXIA ACTIVATES JNK IN THE LIVER DURING HEMORRHAGIC SHOCK , 2004, Shock.
[20] I. Salmon,et al. The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. , 2004, Transplantation proceedings.
[21] Tiziana Bonaldi,et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.
[22] R. Busuttil,et al. Hepatic ischemia/reperfusion injury--a fresh look. , 2003, Experimental and molecular pathology.
[23] J. Oyama,et al. Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice , 2003, Circulation.
[24] G. Su,et al. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[25] Elisabeth L. Humphris,et al. Role of Toll-Like Receptors in Changes in Gene Expression and NF-κB Activation in Mouse Hepatocytes Stimulated with Lipopolysaccharide , 2002, Infection and Immunity.
[26] Y. Morishita,et al. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. , 2002, Surgery.
[27] H. Rüdiger,et al. Mechanism of hepatocyte death after ischemia: Apoptosis versus necrosis , 2001, Hepatology.
[28] M. Magnuson,et al. DNA excision in liver by an albumin‐Cre transgene occurs progressively with age , 2000, Genesis.
[29] J. Engelhardt,et al. Therapeutic approaches for ischemia/reperfusion injury in the liver , 1999, Journal of Molecular Medicine.
[30] W. Reith,et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.
[31] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[32] T. Tani,et al. JNK activation and apoptosis during ischemia-reperfusion. , 1999, Transplantation proceedings.
[33] D. Brenner,et al. Reperfusion after liver transplantation in rats differentially activates the mitogen‐activated protein kinases , 1997, Hepatology.
[34] R. Palmiter,et al. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. , 1987, Genes & development.
[35] N. Shiojiri. Enzymo- and immunocytochemical analyses of the differentiation of liver cells in the prenatal mouse. , 1981, Journal of embryology and experimental morphology.
[36] J. Wang,et al. Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. , 1978, Science.
[37] J. Hughes,et al. Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.